CRT-43 Percutaneous Coronary Intervention for Chronic Total Occlusion in Patients with Chronic Renal Insufficiency  by Rha, Seung-Woon et al.
CABG
CRT-40
Management Of Patients With Or Without Previous Coronary Artery Bypass Surgery
(CABG), Presenting With Acute Coronary Syndrome (ACS).
Ashish Shah, Tim Kinnaird, RIchard Anderson
University Hospital of Wales, Cardiff, United Kingdom
Background: Patients presenting with non ST segment elevation acute coronary
syndrome (NSTEMI-ACS) have higher morbidity and mortality, if treated only
conservatively in comparison to invasive revascularization strategy.
Coronary artery bypass graft (CABG) surgery is a commonly performed procedure.
Nearly 2/3rd of patients suffer graft occlusion within 10 years of surgery (up to 10% grafts
lost within first 12 months). More than 1 in 10 hospital admissions with chest pain in UK
have prior CABG.
Patients with previous CABG, presenting with NSTEMI-ACS is a high risk group,
comparable to those presenting with NSTEMI-ACS, without previous CABG. These
patients are most likely to have moderate to severe diffuse disease, and due to complex
coronary anatomy, it is not always easy to find out the culprit lesion, when they present
with NSTEMI-ACS.
In present work, we wanted to evaluate, whether the patients with previous CABG,
presenting with NSTEMI-ACS are offered similar opportunity of invasive treatment in
comparison to those without previous CABG.
Methods: We analyzed catheter laboratory data from University Hospital of Wales
(UHW), Cardiff, UK from 2008 to 2011, evaluating number of patients presenting with
non ST segment elevation acute coronary syndrome (NSTEMI-ACS) with or without
CABG and their management plan after coronary angiogram.
Results: Total of 5054 patients presenting with NSTEMI-ACS underwent coronary
angiography (266 patients with CABG, 5.3% of total).
In patients without CABG, presenting with NSTEMI-ACS, 27.4% were treated medi-
cally, 51.5% were treated with percutaneous coronary intervention (PCI), 15.6% were refereed
for CABG, 0.7% were refereed for CABG  valve replacement and 4.8% required further
investigations (67.8% of patients were referred for some form of revascularization). Whereas in
patients with previous CABG, who presented with NSTEMI-ACS, 46.5 % were treated
medically, 41% were treated with PCI, 3.4% were refereed for re-do CABG, 0.4% were
refereed for CABG  valve replacement and 8.7% required further investigation.
Conclusion: Despite of being intermediate - high risk, patients with previous CABG
presenting with NSTEMI-ACS, are significantly less likely to be treated with invasive
management strategy (67.8 % vs. 44.8%), in comparison to those presenting with
NSTEMI-ACS without previous CABG. Prognostic impact of the different manage-
ment strategy in this cohort of patients remains unknown.
Cardiovascular Pharmacology
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Does An Abbreviated Dose Of Clopidogrel Negatively Impact The Light Transmission
Aggregometry Response To Platelets?
Mustafa Sawasany
Azhar University, Cairo, Egypt
Long term Dual antiplatelet therapy is critical post stenting to prevent stent thrombosis.
However some patients due to a variety of reasons are unable to continue on the full dose
of clopidogrel. Light transmission aggregometry (LTA) is the current gold standard for
measuring platelet aggregation response to clopidogrel.
Aim: We aim in this study to compare the results of a select group of patients in whom
clopidogrel was given in an abbreviated dose of 3 tablets/week & compared the LTA
response to another group on standard daily 75 mg clopidogrel.
Methods: All patients received a 600 mg loading dose and 75 mg/ day maintenance dose.
Group 1) 76 patients who received 75 mg/day clopidogrel. Group 2) 31 patients who
received 75 mg tab. clopidogrel only 3/week due to associated medical conditions. LTA
was done at 1 & 3 months post inclusion.
Results: The mean age was 54 in Group (1) vs 53 in Group (2). There were significantly
more diabetics in Group (1) vs Group (2) 41/76 vs 10/30 (P.01) as well as more smokers
61% vs 42 % (P.03). All patients received 150 mg Tagamet bid. LTA at 1 month:
Group (1) 72% had an adequate response vs 67% in Group (2) PNS. LTA at 3 Months:
Group (1) 62% had an adequate response vs 59% in Group (2) PNS. There were no
cases of stent thrombosis in either group.
Conclusion: An abbreviated weekly dose of clopidogrel 3/week may provide a similar
level of platelet aggregation inhibition relative to the standard daily dose at 1 & 3 months.
However, the clinical implications require a larger group of patients.
Chronic Total Occlusion
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“Microchannelography” In CTO-PCI
Yoshiki Uehara,1 Shingo Seki,1 Michihiro Yoshimura,2Mitsuyuki Shimizu3
1The Jikei University Katsushika Medical Center, Tokyo, Japan 2The Jikei University
School of Medicine, Tokyo, Japan 3The Jikei University Kashiwa Hospital, Kashiwa,
Japan
Background: It has been reported that microchannels are present inside chronic total
occlusions (CTOs), and soft guidewires with a tip diameter less than 0.014 inch
(Slender-GW) are considered suitable for negotiating them.
Methods: Eighty-five CTOs treated by a single operator between January 2008 and
April 2010 were reviewed. For 28 of them, “microchannelography” (McG) was performed
to reveal microchannels. The McG was provided with tip injections using a microcatheter,
the tip of which was placed at the proximal of the CTO. Following McG, a Slender-GW
was used as the initial guidewire, but was exchanged for a CTO-dedicated guidewire such
as one in the Confienza series when the Slender-GW failed to cross the lesion.
Results: The McG findings were classified into 3 categories: grade 0, without
identifiable microchannels; grade 1, with microchannels only in the proximal part; grade
2, with microchannels throughout the CTO. Grades 0, 1, and 2 were observed in 9, 9, and
10 of the CTO, respectively. Patient and lesion characteristics were comparable between
the 3 McG grades. For grades 1 and 2, Slender-GWs crossed the lesion in all cases except
for one of grade 1. In 5 cases of grade 0, a Confienza Pro guidewire was successful in
crossing the lesion when the Slender-GW could not penetrate it, and penetration was
unsuccessful in 3 cases. Therefore, Slender-GW success rates were 11.1%, 88.8%, and
100% for grade 0, 1, and 2, respectively (P0.001).
Conclusions: The presence of microchannels was evaluated with McG. McG may be
helpful in selecting the guidewire for CTO-PCI.
CRT-43
Percutaneous Coronary Intervention for Chronic Total Occlusion in Patients with
Chronic Renal Insufficiency
Seung-Woon Rha, Byoung Geol Choi, Se Yeon Choi, Sung Il Im, Sun Won Kim,
Jin Oh Na, Cheol Ung Choi, Hong Euy Lim, Jin Won Kim, Eung Ju Kim,
Chang Gyu Park, Hong Seog Seo, Dong Joo Oh
Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea, Republic of
Background: Patients with chronic total occlusive (CTO) have higher prevalence of
diabetes and chronic renal insufficiency (CRI) and further, CTO intervention is definitely
higher chance to use larger amount of contrast media due to longer procedure time. Thus,
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CTO intervention objectively can be more frequently associated acute exacerbation of
CRI or new onset acute renal insufficiency. There have been limited data regarding the
impact of chronic renal insufficiency on major angiographic and clinical outcomes
following percutaneous coronary intervention (PCI) with drug-eluting stents (DES) for
CTO lesions.
Methods: A total 234 consecutive patients with CTO lesion were underwent PCI with
DESs between 2004 and 2010. We compared clinical outcomes of 22 patients with CRI
with 212 patients without CRI for at least up to 6 months. Further, we investigated
whether there are differences between CTO patients with CRI and non-CTO patients
with CRI. All CRI patients were managed with enough prehydration and
N-acetylcysteine administration.
Results: There were no significant differences between the two groups. At 6 months,
major clinical outcomes including cardiac mortality and Q-wave myocardial infarction
(MI) were higher in the CRI group. Further, there was a trend toward higher incidence
of target lesion revascularization (TLR)-major adverse cardiac events (MACES) in the
CRI group (Table).
Conclusions: Patients with CTO lesion and combined CRI at baseline showed worse
mid-term clinical outcomes as compared with those without CRI following successful
CTO PCI with DESs. Updated data will be presented at the time of presentation.
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Multivessel Chronic Total Occlusion Outcomes Can Be Different with Single Vessel
Chronic Total Occlusion?
Seung-Woon Rha, Byoung Geol Choi, Se Yeon Choi, Sung Il Im, Sun Won Kim,
Jin Oh Na, Cheol Ung Choi, Hong Euy Lim, Jin Won Kim, Eung Ju Kim,
Chang Gyu Park, Hong Seog Seo, Dong Joo Oh
Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea, Republic of
Background: Chronic total occlusion (CTO) intervention is still challenging because of
the limited procedural success rate and higher recurrence. It is not clear whether the
angiographic and clinical outcomes may different between patients (pts) with single vessel
CTO (SV-CTO) and multi-vessel CTO (MV-CTO).
Methods: A total of 238 consecutive pts underwent CTO intervention were divided
according to the number of target CTO vessels (SV-CTO: n220 pts, MV-CTO: n18
pts). Six-month angiographic and 24-month clinical outcomes were compared between
the two groups.
Results: The baseline clinical characteristics were balanced between the two groups
except that incidence of myocardial infarction (MI, 61.1 vs. 23.6%, p0.001) and a lower
left ventricular ejection fraction% (LVEF%, 42.0  11.80 vs. 50.28  11.15 p 0.003)
was higher in the MV-CTO group. The overall procedural success rate was a lower in the
MV-CTO group (77.7% vs. 94.0 % p0.009). Procedural characteristics and procedure
related complications including perforation and dissection were not different between the
two groups. Once the CTO was successfully treated, the anngiographic outcomes at 6
months and major clinical outcomes up to 24 months were similar between the two
groups (Table).
Conclusions: Baseline characteristics were worse and the procedural success rate was
lower in the MV-CTO group. However, once the CTO lesion was successfully
recanalyzed, the safety profiles, complications, mid-term angiographic and clinical
outcomes up to 24 months were similar between the two groups.
Complex Coronary Intervention
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Use Of Impella® In Complex High Risk Percutaneous Coronary Intervention
Roberto Baglini, Andrea Amaducci, Giuseppe D’Ancona, Gabriele DiGesaro,
Giuseppe Romano
IsMeTT, UPMC, Palermo, Italy
Background: IMPELLA® is a new vascular micro-axial blood pump with a flow of 2.5
L/min. It allows the unloading of the left ventricle.
Methods: 11 consecutive male patients (mean age 657 years), with coronary artery
disease (9 with three vessels disease, 2 with left main stenosis and two coronary vessels
disease, 5 of them with last remaining vessel) and severe left ventricular dysfunction (mean
EF 244%) were enrolled. All were poor surgical candidates because of severe co-
morbidities: diabetes 63%, renal insufficiency on dialysis 27%, severe respiratory insuffi-
ciency 18%. Coronary artery lesions were 70% type C and 30% type B2. All these patients
underwent high-risk PCI with Impella support. Cardiac index (CI), pulmonary wedge
pressure (PWP and derived parameters were monitored by Swan-Ganz Catheter, while
LVEF was measured from TEE.
Results: Success rate was 100% without any device-related adverse event. The average
time of IMPELLA® support was 4216 min. No pts needed pharmacologic inotropic
support. During IMPELLA® there was a significant improvement of CI (from 2.150,8
l/min/sm to 2.830,3 l/min/sm, p0.01), stroke volume (from 37.215 ml to 49.611
ml, p 0.01), mean blood pressure from 558 mmHg to 647 mmHg (p 0.001) while
PWP pulmonary vascular resistances significantly decreased (from 24.8mmHg11 to
20.76 mmHg, and 723146 dyne/sec/cm-5 to 62093 dyne/sec/cm-5, p0.01).
Mean coronary occlusion time during IMPELLA® support was 18418 sec.
During the procedures LV ejection fraction, stroke volume, CI, PWP, mean blood
pressure and pulmonary vascular resistance did not show any significant changes.
Conclusion: Left Ventricle Unloading with Impella during complex PCI in pts with
severe left ventricular dysfunction is able to improve hemodynamic basal condition, and to
maintain it during prolonged coronary occlusion.
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